SCHEDULE: Madrone Capital, Penner Disclose Pacific Biosciences Stake
Beneficial Ownership Disclosure
Madrone Capital Partners and related entities, including Gregory Penner, filed an amended Schedule 13G disclosing their beneficial ownership in Pacific Biosciences of California, Inc.
Summary
- Madrone Capital Partners, LLC, Madrone Opportunity Fund, L.P., Shimoda Holdings, LLC, Gregory Penner, Jameson J. McJunkin, and Thomas Patterson filed an Amendment No. 5 to Schedule 13G.
- The filing reports beneficial ownership of common stock in Pacific Biosciences of California, Inc. (PACB).
- Gregory Penner, individually, beneficially owns 8,476,089 shares, representing 2.8% of the class.
- Madrone Capital Partners, LLC, Madrone Opportunity Fund, L.P., Jameson J. McJunkin, and Thomas Patterson each beneficially own 4,976,089 shares, representing 1.7% of the class.
- Shimoda Holdings, LLC beneficially owns 3,500,000 shares, representing 1.2% of the class.
- The percentages are based on 300,370,611 shares of the Issuer's common stock outstanding as of July 31, 2025.
- The reporting persons expressly disclaim status as a 'group' for purposes of this Schedule 13G.
- The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine disclosure of beneficial ownership and does not contain performance or forward-looking statements.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of beneficial ownership and does not provide specific industry context or trends. It reflects an institutional and individual investor's stake in a publicly traded company within the biotechnology or life sciences sector, specifically in genomics.
Stakeholder Impact
- Shareholders: Provides transparency on significant institutional and individual holdings, which can influence market perception of stability and investor confidence.
Key Dates
| Date | Description |
|---|---|
| 2025-07-31 | Date of shares outstanding calculation for percentage of class, as reported in the Issuer's Quarterly Report on Form 10-Q. |
| 2025-09-30 | Date of event which requires the filing of this statement. |
| 2025-11-14 | Date of signing the Schedule 13G amendment by the reporting persons. |
Keywords
Pacific Biosciences, PACB, Madrone Capital Partners, Madrone Opportunity Fund, Shimoda Holdings, Gregory Penner, Beneficial Ownership, Schedule 13G, SEC Filing, Institutional Ownership, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.